Fast forward 12 months and POH is now a very very different beast.
This is very true. If POH could reach 25c on a quarter's worth of Bodyshaper sales and the promise of an upcoming Phase 3, then a year on, what sort of valuation might investors place on POH this time around? Quite simply there are multiples of products now becoming commercialised and producing cash. This is the point where companies typically get re-rated. I am confident that our time is near (relatively speaking).
Just don't go on that holiday again just yet CHarch.
great times, page-22
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |